A new approach to predict evolution of influenza viruses can enhance vaccine efficacy

December 7, 2015, University of Helsinki

New results from a study performed at the University of Helsinki suggest that genomic information from circulating influenza viruses can help in producing more efficient seasonal vaccines. The researchers were able to develop a simple approach for reliable real-time tracking and prediction of viral evolution based on whole-genome sequences of influenza viruses.

Influenza vaccines have been developed to prevent the yearly outbreaks of this respiratory illness and to protect people at risk from developing severe disease. In contrast to many other vaccines, need to be reformulated each year because circulating influenza viruses continuously evolve. This evolution is due to the ability of viruses to accumulate new mutations in their genome. Especially critical are those genomic regions that encode viral proteins recognized by the human immune system.

World Health Organization (WHO) is responsible for predicting the influenza that will be most common during the next season and for giving recommendations on the particular virus strains that should be used for producing the vaccines for the next . The effectiveness of the vaccines varies from year to year and was modest for the previous season. This could be due to antigenic mismatch between the circulating and the recommended by the WHO.

Researchers from the Institute for Molecular Medicine Finland, FIMM, the University of Helsinki, have now analysed thousands of complete genome sequences of influenza A(H1N1) and A(H3N2) strains representing different geographic regions. The study was done in collaboration with researchers from Singapore and United Kingdom. By utilizing biostatistical methods, the team was able to identify several genetic variants that changed the structure of the influenza proteins and that were present in surprisingly many of the strains studied.

"We named these characteristic variants as evolutionary markers as they seemed to contain valuable information regarding the viral evolution," explains Denis Kainov, the leader of the research team.

Furthermore, the group was able to show that both influenza subtypes acquired their own sets of these evolutionary markers. Importantly, many of these markers were not present in the virus strains used for the vaccine development during the last season.

"We believe that our results and methodology could further improve vaccine strain selection process and, thereby, enhance vaccine efficacy. Each year a substantial number of Finns gets influenza. We estimated that if the vaccination efficacy increases by 50%, this would save up to 8 000 people from getting the disease in Finland alone. Our team proposes using the strains containing all the identified evolutionary markers as vaccine candidates for upcoming seasons," Kainov continues.

Explore further: Scientists pinpoint mutations responsible for ineffective 2014-2015 flu vaccine

More information: Sergei S. Belanov et al. Genome-wide analysis of evolutionary markers of human influenza A(H1N1)pdm09 and A(H3N2) viruses may guide selection of vaccine strain candidates, Genome Biology and Evolution (2015). DOI: 10.1093/gbe/evv240

Related Stories

Scientists pinpoint mutations responsible for ineffective 2014-2015 flu vaccine

June 25, 2015
Viruses like influenza have the ability to mutate over time, and given that the flu vaccines administered during the 2014-2015 season were largely ineffective at preventing the spread of the flu, it appears the virus that ...

Enhanced flu protection: Adding a second strain of B flu lessens likelihood of mismatched vaccine

March 13, 2015
A flu vaccine given just under the surface of the skin that includes four strains of inactivated influenza could be more protective than a similar flu vaccine containing only three strains, Saint Louis University research ...

CDC tweaking flu vaccine for better protection

June 5, 2015
(HealthDay)—Having acknowledged that the 2014-2015 flu vaccine was mismatched to the circulating influenza strains, U.S. health officials have ramped up next season's shots for broader protection.

Influenza vaccines provide moderate protection throughout the entire flu season

August 24, 2015
Individuals who received the flu vaccine were protected for up to 6 months post-vaccination, the duration of most flu seasons, according to a study presented at the 2015 International Conference on Emerging Infectious Diseases.

Flu study, on hold, yields new vaccine technology

September 2, 2015
Vaccines to protect against an avian influenza pandemic as well as seasonal flu may be mass produced more quickly and efficiently using technology described today by researchers at the University of Wisconsin-Madison in the ...

FDA approves first 4-in-1 flu vaccine

February 29, 2012
Federal health officials have approved the first vaccine that protects against four strains of the common flu, offering one additional layer of protection against the influenza virus that affects millions each year.

Recommended for you

Researchers make essential imaging tests safer for people at risk of acute kidney injury

October 15, 2018
Every year, millions of people undergo medical tests and procedures, such as coronary angiography, which use intravascular contrast dyes. "For the majority of patients, these are safe and necessary procedures. However, about ...

Medical marijuana might help MS patients, but uncertainty remains

October 13, 2018
Medical products derived from marijuana might have a mild benefit in treating symptoms of multiple sclerosis, based on reports from patients.

Do not give decongestants to young children for common cold symptoms, say experts

October 11, 2018
Decongestants should not be given to children under 6—and given with caution in children under 12—as there is no evidence that they alleviate symptoms such as a blocked or runny nose, and their safety is unclear, say ...

New techniques can detect Lyme disease weeks before current tests

October 11, 2018
Researchers have developed techniques to detect Lyme disease bacteria weeks sooner than current tests, allowing patients to start treatment earlier.

Pneumonia-causing bacteria can be spread by nose picking and rubbing

October 11, 2018
Pneumonia-causing bacteria can be spread through picking and rubbing the nose, according to new research published in the European Respiratory Journal.

Plant compound found to have therapeutic effect on complications from snakebites

October 11, 2018
Rutin, a flavonoid, may complement antivenom as an effective co-treatment for envenoming from Bothrops jaraca.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.